StockDuty ← Dashboard Nov 04, 2026 09:35 PM ET
SignalCorporate

Adaptive Biotechnologies GAAP EPS of $0.02 beats by $0.11, revenue of $83.9M beats by $12.3M

GAAP EPS beat by $0.11 and revenue beat by $12.3M.

What changed
GAAP EPS beat by $0.11 and revenue beat by $12.3M.
Why it matters
GAAP EPS beat by $0.11 and revenue beat by $12.3M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →